Suppr超能文献

B细胞和抗体在获得性抗结核分枝杆菌免疫中的作用。

Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

作者信息

Achkar Jacqueline M, Chan John, Casadevall Arturo

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461 Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.

出版信息

Cold Spring Harb Perspect Med. 2014 Oct 9;5(3):a018432. doi: 10.1101/cshperspect.a018432.

Abstract

Accumulating evidence has documented a role for B cells and antibodies (Abs) in the immunity against Mycobacterium tuberculosis (Mtb). Passive transfer studies with monoclonal antibodies (mAbs) against mycobacterial antigens have shown protection against the tubercle bacillus. B cells and Abs are believed to contribute to an enhanced immune response against Mtb by modulating various immunological components in the infected host including the T-cell compartment. Nevertheless, the extent and contribution of B cells and Abs to protection against Mtb remains uncertain. In this article we summarize the most relevant findings supporting the role of B cells and Abs in the defense against Mtb and discuss the potential mechanisms of protection.

摘要

越来越多的证据表明B细胞和抗体在抗结核分枝杆菌(Mtb)免疫中发挥作用。针对分枝杆菌抗原的单克隆抗体(mAb)的被动转移研究已显示出对结核杆菌的保护作用。B细胞和抗体被认为通过调节感染宿主中的各种免疫成分(包括T细胞区室)来促进针对Mtb的增强免疫反应。然而,B细胞和抗体对抵抗Mtb的保护作用的程度和贡献仍不确定。在本文中,我们总结了支持B细胞和抗体在抵御Mtb中作用的最相关发现,并讨论了潜在的保护机制。

相似文献

1
Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.
Cold Spring Harb Perspect Med. 2014 Oct 9;5(3):a018432. doi: 10.1101/cshperspect.a018432.
2
B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
Immunol Rev. 2015 Mar;264(1):167-81. doi: 10.1111/imr.12276.
3
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.
Front Immunol. 2021 Feb 18;12:640168. doi: 10.3389/fimmu.2021.640168. eCollection 2021.
4
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.
Semin Immunol. 2014 Dec;26(6):588-600. doi: 10.1016/j.smim.2014.10.005. Epub 2014 Oct 28.
5
Antibodies and tuberculosis: finally coming of age?
Nat Rev Immunol. 2018 Sep;18(9):591-596. doi: 10.1038/s41577-018-0028-0.
6
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.
Adv Exp Med Biol. 2013;783:225-50. doi: 10.1007/978-1-4614-6111-1_12.
8
Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.
EMBO Mol Med. 2016 Nov 2;8(11):1325-1339. doi: 10.15252/emmm.201606330. Print 2016 Nov.
9
Antibody-mediated immunity against tuberculosis: implications for vaccine development.
Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009.
10
Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy.
FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):9-16. doi: 10.1016/S0928-8244(03)00172-X.

引用本文的文献

1
In-silico development of a novel TLR2-mediating multi-epitope vaccine against .
In Silico Pharmacol. 2025 Feb 25;13(1):34. doi: 10.1007/s40203-025-00322-8. eCollection 2025.
3
Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.
Exploration (Beijing). 2024 Mar 5;4(5):20230138. doi: 10.1002/EXP.20230138. eCollection 2024 Oct.
4
From pathogenesis to antigens: the key to shaping the future of TB vaccines.
Front Immunol. 2024 Jul 23;15:1440935. doi: 10.3389/fimmu.2024.1440935. eCollection 2024.
6
Role of B Cells in Mycobacterium Tuberculosis Infection.
Vaccines (Basel). 2023 May 6;11(5):955. doi: 10.3390/vaccines11050955.
7
B cell phenotypes and maturation states in cows naturally infected with Mycobacterium avium subsp. Paratuberculosis.
PLoS One. 2022 Dec 7;17(12):e0278313. doi: 10.1371/journal.pone.0278313. eCollection 2022.
8
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.
Front Immunol. 2021 Feb 18;12:640168. doi: 10.3389/fimmu.2021.640168. eCollection 2021.
9
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19.
mBio. 2021 Mar 2;12(2):e03372-20. doi: 10.1128/mBio.03372-20.
10
Predicted Structural Variability of PPE18 Protein With Immunological Implications Among Clinical Strains.
Front Microbiol. 2021 Jan 8;11:595312. doi: 10.3389/fmicb.2020.595312. eCollection 2020.

本文引用的文献

3
Blood Tfh cells come with colors.
Immunity. 2013 Oct 17;39(4):629-30. doi: 10.1016/j.immuni.2013.09.011.
5
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Clin Vaccine Immunol. 2013 Nov;20(11):1683-9. doi: 10.1128/CVI.00427-13. Epub 2013 Aug 28.
7
Infectious risks associated with biologics.
Adv Exp Med Biol. 2013;764:151-8. doi: 10.1007/978-1-4614-4726-9_12.
8
Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies.
Cell Host Microbe. 2013 Apr 17;13(4):417-28. doi: 10.1016/j.chom.2013.03.001.
9
TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species.
Cell. 2013 Apr 25;153(3):521-34. doi: 10.1016/j.cell.2013.03.022. Epub 2013 Apr 11.
10
Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.
Tuberculosis (Edinb). 2013 Jul;93(4):448-55. doi: 10.1016/j.tube.2013.03.001. Epub 2013 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验